BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 16984658)

  • 41. Hospital electronic medical record-based public health surveillance system deployed during the 2002 Winter Olympic Games.
    Gundlapalli AV; Olson J; Smith SP; Baza M; Hausam RR; Eutropius LJ; Pestotnik SL; Duncan K; Staggers N; Pincetl P; Samore MH
    Am J Infect Control; 2007 Apr; 35(3):163-71. PubMed ID: 17433939
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Initial evaluation of the early aberration reporting system--Florida.
    Zhu Y; Wang W; Atrubin D; Wu Y
    MMWR Suppl; 2005 Aug; 54():123-30. PubMed ID: 16177703
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A secure protocol for protecting the identity of providers when disclosing data for disease surveillance.
    El Emam K; Hu J; Mercer J; Peyton L; Kantarcioglu M; Malin B; Buckeridge D; Samet S; Earle C
    J Am Med Inform Assoc; 2011 May; 18(3):212-7. PubMed ID: 21486880
    [TBL] [Abstract][Full Text] [Related]  

  • 44. PHSkb: a knowledgebase to support notifiable disease surveillance.
    Doyle TJ; Ma H; Groseclose SL; Hopkins RS
    BMC Med Inform Decis Mak; 2005 Aug; 5():27. PubMed ID: 16105177
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Syndromic surveillance. Reports from a national conference, 2003.
    Centers for Disease Control and Prevention (CDC)
    MMWR Suppl; 2004 Sep; 53():1-264. PubMed ID: 15714619
    [No Abstract]   [Full Text] [Related]  

  • 46. Three years of emergency department gastrointestinal syndromic surveillance in New York City: what have we found?
    Balter S; Weiss D; Hanson H; Reddy V; Das D; Heffernan R
    MMWR Suppl; 2005 Aug; 54():175-80. PubMed ID: 16177711
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Connecting health departments and providers: syndromic surveillance's last mile.
    Daniel JB; Heisey-Grove D; Gadam P; Yih W; Mandl K; Demaria A; Platt R
    MMWR Suppl; 2005 Aug; 54():147-50. PubMed ID: 16177706
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Our first line of defense against bioterrorism part 2.
    Simpson RL
    Nurs Manage; 2002 May; 33(5):10, 11. PubMed ID: 12006878
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Draft framework for evaluating syndromic surveillance systems.
    Sosin DM
    J Urban Health; 2003 Jun; 80(2 Suppl 1):i8-13. PubMed ID: 12791773
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Guidelines to implement medical examiner/coroner-based surveillance for fatal infectious diseases and bioterrorism ("Med-X").
    Nolte KB; Fischer M; Reagan S; Lynfield R;
    Am J Forensic Med Pathol; 2010 Dec; 31(4):308-12. PubMed ID: 20683243
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Results from the fielding of the Bio-surveillance Analysis, Feedback, Evaluation and Response (B-SAFER) system in Albuquerque, New Mexico.
    Forslund D; Umland E; Brillman JC; Joyce E; Froman P; Burr T; Judd SL; Picard R; Wokoun D; Joner M; Sewell CM
    AMIA Annu Symp Proc; 2003; 2003():842. PubMed ID: 14728347
    [TBL] [Abstract][Full Text] [Related]  

  • 52. An evaluation model for syndromic surveillance: assessing the performance of a temporal algorithm.
    Buckeridge DL; Switzer P; Owens D; Siegrist D; Pavlin J; Musen M
    MMWR Suppl; 2005 Aug; 54():109-15. PubMed ID: 16177701
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Deciphering data anomalies in BioSense.
    Sokolow LZ; Grady N; Rolka H; Walker D; McMurray P; English-Bullard R; Loonsk J
    MMWR Suppl; 2005 Aug; 54():133-9. PubMed ID: 16177704
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A shot in the arm for public health. Weak systems require reinforcement at all levels.
    Lee CD
    J AHIMA; 2003 Jan; 74(1):36-8, 40, 42; quiz 45-6. PubMed ID: 12530345
    [No Abstract]   [Full Text] [Related]  

  • 55. Syndromic surveillance.
    Healthc Hazard Manage Monit; 2003 Apr; 16(8):1-6. PubMed ID: 12723301
    [No Abstract]   [Full Text] [Related]  

  • 56. Syndromic surveillance on the epidemiologist's desktop: making sense of much data.
    Hurt-Mullen KJ; Coberly J
    MMWR Suppl; 2005 Aug; 54():141-6. PubMed ID: 16177705
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Implementing syndromic surveillance: a practical guide informed by the early experience.
    Mandl KD; Overhage JM; Wagner MM; Lober WB; Sebastiani P; Mostashari F; Pavlin JA; Gesteland PH; Treadwell T; Koski E; Hutwagner L; Buckeridge DL; Aller RD; Grannis S
    J Am Med Inform Assoc; 2004; 11(2):141-50. PubMed ID: 14633933
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [2008 G8 Hokkaido Toyako Summit Meeting Syndrome Surveillance].
    Ohkusa Y; Yamaguchi R; Sugiura H; Sugawara T; Yoshida M; Shimada C; Hori N; Sugishita Y; Yasui Y; Sunagawa T; Matsui T; Taniguchi K; Tada Y; Taya K; Imamura T; Okabe N
    Kansenshogaku Zasshi; 2009 May; 83(3):236-44. PubMed ID: 19522307
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Use of automated ambulatory-care encounter records for detection of acute illness clusters, including potential bioterrorism events.
    Lazarus R; Kleinman K; Dashevsky I; Adams C; Kludt P; DeMaria A; Platt R
    Emerg Infect Dis; 2002 Aug; 8(8):753-60. PubMed ID: 12141958
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Key design elements of a data utility for national biosurveillance: event-driven architecture, caching, and Web service model.
    Tsui FC; Espino JU; Weng Y; Choudary A; Su HD; Wagner MM
    AMIA Annu Symp Proc; 2005; 2005():739-43. PubMed ID: 16779138
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.